Dr. Keene Wei, Founder of Vitsgen, Invited to Speak at the 3rd Global Nuclear Medicine Development Summit 2026, Sharing Cutting-Edge Insights on Radiopharmaceutical Conjugate Design
Dr. Keene Wei, Founder of VitsGen, to Present Frontier Insights on Intelligent Design of Radiopharmaceuticals at the 2nd TRP Targeted Radiopharmaceutical Summit
VitsGen’s IND for Novel PSMA-Targeting Radioligand Therapy (177Lu-PSMA-VG01) in mCRPC Accepted by China’s CDE
VitsGen 21st Century Medicinal Chemistry Delivering Precision Radioligand Therapy
VitsGen CEO & CSO Invited Speakers at TRP US
